MedPath

INVOKAMET

INVOKAMET

Approved
DIN Number

02455404

Drug Class

Human

Market Date

Jun 28, 2016

Company
HC

Janssen Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02455404
AIG Number0258190001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BD16 METFORMIN AND CANAGLIFLOZIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:20.04
Health Canada Classification

ACTIVE INGREDIENTS (2)

CANAGLIFLOZINActive
Strength: 50 MG
Monograph: CANAGLIFLOZIN
METFORMIN HYDROCHLORIDEActive
Strength: 500 MG
Monograph: METFORMIN HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.